555 related articles for article (PubMed ID: 27386931)
1. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
Pietruszewska W; Bojanowska-Poźniak K; Kobos J
Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
[TBL] [Abstract][Full Text] [Related]
2. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
[TBL] [Abstract][Full Text] [Related]
4. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
[TBL] [Abstract][Full Text] [Related]
5. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
Soini Y; Satta J; Määttä M; Autio-Harmainen H
J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
[TBL] [Abstract][Full Text] [Related]
6. Expression of MMP and TIMP mRNA in peripheral blood leukocytes of patients with invasive ductal carcinoma of the breast.
Wieczorek E; Galicki M; Tomasik B; Krol M; Jablonska E; Fendler W; Gromadzinska J; Morawiec Z; Wasowicz W; Reszka E
Int J Biol Markers; 2016 Jul; 31(3):e309-16. PubMed ID: 27032379
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
[TBL] [Abstract][Full Text] [Related]
8. Is determination of matrix metalloproteinases and their tissue inhibitors serum concentrations useful in patients with gastroenteropancreatic and bronchopulmonary neuroendocrine neoplasms?
Blicharz-Dorniak J; Kos-Kudła B; Foltyn W; Kajdaniuk D; Marek B; Zemczak A; Strzelczyk J
Endokrynol Pol; 2012; 63(6):470-6. PubMed ID: 23339005
[TBL] [Abstract][Full Text] [Related]
9. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
[TBL] [Abstract][Full Text] [Related]
10. High variability in MMP2/TIMP2 and MMP9/TIMP1 expression in secondary liver tumors.
Avădanei R; Căruntu ID; Amălinei C; Lozneanu L; Balan R; Grigoraş A; Ciobanu Apostol D; Giuşcă SE
Rom J Morphol Embryol; 2013; 54(3):479-85. PubMed ID: 24068394
[TBL] [Abstract][Full Text] [Related]
11. Effects of a vegetable extract from Lupinus albus (LU105) on the production of matrix metalloproteinases (MMP1, MMP2, MMP9) and tissue inhibitor of metalloproteinases (TIMP1, TIMP2) by human gingival fibroblasts in culture.
Gaultier F; Foucault-Bertaud A; Lamy E; Ejeil AL; Dridi SM; Piccardi N; Piccirilli A; Msika P; Godeau G; Gogly B
Clin Oral Investig; 2003 Dec; 7(4):198-205. PubMed ID: 12802622
[TBL] [Abstract][Full Text] [Related]
12. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
13. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2.
Jacomasso T; Trombetta-Lima M; Sogayar MC; Winnischofer SM
Melanoma Res; 2014 Feb; 24(1):32-9. PubMed ID: 24335752
[TBL] [Abstract][Full Text] [Related]
15. Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease.
Serralheiro P; Novais A; Cairrão E; Maia C; Costa Almeida CM; Verde I
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267209
[TBL] [Abstract][Full Text] [Related]
16. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
O-Charoenrat P; Khantapura P
Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
[TBL] [Abstract][Full Text] [Related]
17. TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.
Ashworth Briggs EL; Toh T; Eri R; Hewitt AW; Cook AL
Mol Vis; 2015; 21():1162-72. PubMed ID: 26539028
[TBL] [Abstract][Full Text] [Related]
18. Changes in Gene and Protein Expression of Metalloproteinase-2 and -9 and Their Inhibitors TIMP2 and TIMP3 in Different Parts of Fluoride-Exposed Rat Brain.
Łukomska A; Baranowska-Bosiacka I; Dec K; Pilutin A; Tarnowski M; Jakubczyk K; Żwierełło W; Skórka-Majewicz M; Chlubek D; Gutowska I
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396569
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer.
Gong YL; Xu GM; Huang WD; Chen LB
J Surg Oncol; 2000 Feb; 73(2):95-9. PubMed ID: 10694645
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer.
Danilewicz M; Sikorska B; Wagrowska-Danilewicz M
Med Sci Monit; 2003 Mar; 9(3):MT42-7. PubMed ID: 12640351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
